Taken together, our findings indicated that the CD8 checkpoint blockade promoted vascular regeneration by blocking the skewed commitment of effector CD8+ T-cells and inhibiting their production of cytotoxic factors after ischemic injury in T2D mice. Here, CD8A is linked to type 2 diabetes mellitus.